Glucose Tolerance in Healthy Overweight Adults

Inclusion criteria

• Fasting blood glucose level of ≥ 70mg/dL and ≤ 125 mg/dL.
• Subject states that he/she does not have type 1 or 2 diabetes.
• Subject is overweight as defined as waist circumference ≥ 101 cm (40 inches) male; ≥ 88 cm (35 inches) female.
• Subject's BMI is ≥ 25 kg/m2.
• Subject's blood pressure is < 140 mm Hg systolic and < 90 mm Hg diastolic.
• Subject is between 20 and 45 years of age, inclusive.
• Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit.
• If female is of childbearing potential, is practicing birth control
• If subject is on a chronic medication such as a thyroid medication or hormone therapy, has been on constant dosage for at least two months prior to screening visit.

Exclusion criteria

• Subject is eating a low carbohydrate diet such as Atkins, Zone, or South Beach diet plan.
• Subject states that he/she has current infection, has had inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior to screening visit.
• Subject states that he/she has an active malignancy.
• Subject states that he/she has had a significant cardiovascular event ≤ six months prior to screening visit; or stated history of congestive heart failure.
• Subject states that he/she has end-stage organ failure or is status post organ transplant.
• Subject states that he/she has a history of renal disease.
• Subject states that he/she has current hepatic disease.
• Subject states that he/she has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
• Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit that could profoundly affect blood glucose.
• Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit to control hypertension or cholesterol.
• Subject states that he/she has clotting or bleeding disorders.